Johanna Nokso-Koivisto1, Tal Marom, Tasnee Chonmaitree. 1. aDepartment of Otorhinolaryngology, Helsinki University Central Hospital, Helsinki, Finland bDepartment of Otolaryngology-Head and Neck Surgery, Edith Wolfson Medical Center, Tel Aviv University Sackler School of Medicine, Holon, Israel cDivision of Infectious Diseases, Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Abstract
PURPOSE OF REVIEW: Acute otitis media occurs as a complication of viral upper respiratory tract infection. Bacterial otopathogens and respiratory viruses interact and play important roles in acute otitis media development. A better understanding of viral and bacterial interactions may lead to innovative ways to lessen the burden of this common childhood disease. RECENT FINDINGS: There has been increasing evidence that acute otitis media occurs during upper respiratory infection, even in the absence of nasopharyngeal bacterial colonization. Among the types of viruses associated with acute otitis media, respiratory syncytial virus continues to be the most commonly detected. It is still unclear whether viral load plays an important role in acute otitis media development, but symptomatic upper respiratory tract infection (as opposed to asymptomatic viral infection) is crucial. Widespread use of bacterial and viral vaccines in young children, including pneumococcal conjugate and influenza vaccines, has led to the reduction in otitis media-related healthcare use between 2001 and 2011. There has been no new vaccine against respiratory viruses other than influenza. SUMMARY: Progress has been made toward the reduction of the burden of acute otitis media in the last decade. Success in reducing acute otitis media incidence will rely mainly on prevention of nasopharyngeal otopathogen colonization, as well as reduction in the incidence of viral upper respiratory tract infection.
PURPOSE OF REVIEW: Acute otitis media occurs as a complication of viral upper respiratory tract infection. Bacterial otopathogens and respiratory viruses interact and play important roles in acute otitis media development. A better understanding of viral and bacterial interactions may lead to innovative ways to lessen the burden of this common childhood disease. RECENT FINDINGS: There has been increasing evidence that acute otitis media occurs during upper respiratory infection, even in the absence of nasopharyngeal bacterial colonization. Among the types of viruses associated with acute otitis media, respiratory syncytial virus continues to be the most commonly detected. It is still unclear whether viral load plays an important role in acute otitis media development, but symptomatic upper respiratory tract infection (as opposed to asymptomatic viral infection) is crucial. Widespread use of bacterial and viral vaccines in young children, including pneumococcal conjugate and influenza vaccines, has led to the reduction in otitis media-related healthcare use between 2001 and 2011. There has been no new vaccine against respiratory viruses other than influenza. SUMMARY: Progress has been made toward the reduction of the burden of acute otitis media in the last decade. Success in reducing acute otitis media incidence will rely mainly on prevention of nasopharyngeal otopathogen colonization, as well as reduction in the incidence of viral upper respiratory tract infection.
Authors: Terho Heikkinen; Stan L Block; Seth L Toback; Xionghua Wu; Christopher S Ambrose Journal: Pediatr Infect Dis J Date: 2013-06 Impact factor: 2.129
Authors: Melinda M Pettigrew; Janneane F Gent; Richard B Pyles; Aaron L Miller; Johanna Nokso-Koivisto; Tasnee Chonmaitree Journal: J Clin Microbiol Date: 2011-09-07 Impact factor: 5.948
Authors: Stan L Block; Terho Heikkinen; Seth L Toback; Wei Zheng; Christopher S Ambrose Journal: Pediatr Infect Dis J Date: 2011-03 Impact factor: 2.129
Authors: Selma P Wiertsema; Glenys R Chidlow; Lea-Ann S Kirkham; Karli J Corscadden; Eva N Mowe; Shyan Vijayasekaran; Harvey L Coates; Gerald B Harnett; Peter C Richmond Journal: J Med Virol Date: 2011-11 Impact factor: 2.327
Authors: Tasnee Chonmaitree; Pedro Alvarez-Fernandez; Kristofer Jennings; Rocio Trujillo; Tal Marom; Michael J Loeffelholz; Aaron L Miller; David P McCormick; Janak A Patel; Richard B Pyles Journal: Clin Infect Dis Date: 2014-09-09 Impact factor: 9.079
Authors: Stephanie R Bialek; Donna Allen; Francisco Alvarado-Ramy; Ray Arthur; Arunmozhi Balajee; David Bell; Susan Best; Carina Blackmore; Lucy Breakwell; Andrew Cannons; Clive Brown; Martin Cetron; Nora Chea; Christina Chommanard; Nicole Cohen; Craig Conover; Antonio Crespo; Jeanean Creviston; Aaron T Curns; Rebecca Dahl; Stephanie Dearth; Alfred DeMaria; Fred Echols; Dean D Erdman; Daniel Feikin; Mabel Frias; Susan I Gerber; Reena Gulati; Christa Hale; Lia M Haynes; Lea Heberlein-Larson; Kelly Holton; Kashef Ijaz; Minal Kapoor; Katrin Kohl; David T Kuhar; Alan M Kumar; Marianne Kundich; Susan Lippold; Lixia Liu; Judith C Lovchik; Larry Madoff; Sandra Martell; Sarah Matthews; Jessica Moore; Linda R Murray; Shauna Onofrey; Mark A Pallansch; Nicki Pesik; Huong Pham; Satish Pillai; Pam Pontones; Kimberly Pringle; Scott Pritchard; Sonja Rasmussen; Shawn Richards; Michelle Sandoval; Eileen Schneider; Anne Schuchat; Kristine Sheedy; Kevin Sherin; David L Swerdlow; Jordan W Tappero; Michael O Vernon; Sharon Watkins; John Watson Journal: MMWR Morb Mortal Wkly Rep Date: 2014-05-16 Impact factor: 17.586
Authors: Stephen L Toone; Michelle Ratkiewicz; Laura A Novotny; Binh L Phong; Lauren O Bakaletz Journal: Infect Immun Date: 2020-08-19 Impact factor: 3.441
Authors: Rustin G Kashani; Marcel C Młyńczak; David Zarabanda; Paola Solis-Pazmino; David M Huland; Iram N Ahmad; Surya P Singh; Tulio A Valdez Journal: Sci Rep Date: 2021-06-15 Impact factor: 4.379